Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1547
-0.0028 (-1.78%)
At close: Aug 21, 2026, 4:00 PM EDT
0.1555
+0.0008 (0.52%)
After-hours: Aug 21, 2026, 7:59 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $75.62 million as of August 21, 2026. Its market cap has decreased by -82.94% in one year.
Market Cap
75.62M
Enterprise Value
58.67M
1-Year Change
-82.94%
Ranking
Category
Stock Price
$0.15
ChartMarket Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $75.62M, a decrease of -92.40%. That is a compound annual growth rate of -28.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 75.62M | -89.46% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 79.90M |
| Telomir Pharmaceuticals | 77.72M |
| Annovis Bio | 77.43M |
| NeurAxis | 77.23M |
| Alterity Therapeutics | 76.40M |
| Serina Therapeutics | 72.90M |
| LeonaBio | 72.19M |
| Pliant Therapeutics | 71.52M |